These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35706127)

  • 1. Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis.
    Karlow JA; Devarakonda S; Xing X; Jang HS; Govindan R; Watson M; Wang T
    Cancer Res; 2022 Aug; 82(15):2692-2703. PubMed ID: 35706127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases.
    Xu Y; Huang Z; Yu X; Chen K; Fan Y
    Mol Brain; 2021 Dec; 14(1):176. PubMed ID: 34952628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers.
    Altenberger C; Heller G; Ziegler B; Tomasich E; Marhold M; Topakian T; Müllauer L; Heffeter P; Lang G; End-Pfützenreuter A; Döme B; Arns BM; Klepetko W; Zielinski CC; Zöchbauer-Müller S
    Mol Cancer; 2017 Jan; 16(1):1. PubMed ID: 28093071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
    Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
    Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
    [No Abstract]   [Full Text] [Related]  

  • 6. Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor.
    Kuo KT; Huang WC; Bamodu OA; Lee WH; Wang CH; Hsiao M; Wang LS; Yeh CT
    Clin Epigenetics; 2018 Aug; 10(1):107. PubMed ID: 30092824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.
    Watanabe K; Amano Y; Ishikawa R; Sunohara M; Kage H; Ichinose J; Sano A; Nakajima J; Fukayama M; Yatomi Y; Nagase T; Ohishi N; Takai D
    Cancer Med; 2015 Oct; 4(10):1573-82. PubMed ID: 26256448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.
    Wagner KW; Alam H; Dhar SS; Giri U; Li N; Wei Y; Giri D; Cascone T; Kim JH; Ye Y; Multani AS; Chan CH; Erez B; Saigal B; Chung J; Lin HK; Wu X; Hung MC; Heymach JV; Lee MG
    J Clin Invest; 2013 Dec; 123(12):5231-46. PubMed ID: 24200691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
    Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
    Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of tumor and two types of paratumoral tissues highlighted epigenetic regulation of transcription during field cancerization in non-small cell lung cancer.
    Wang Q; Wu L; Yu J; Li G; Zhang P; Wang H; Shao L; Liu J; Shen W
    BMC Med Genomics; 2022 Mar; 15(1):66. PubMed ID: 35313869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation of microRNA-coding genes in non-small-cell lung cancer patients.
    Heller G; Altenberger C; Steiner I; Topakian T; Ziegler B; Tomasich E; Lang G; End-Pfützenreuter A; Zehetmayer S; Döme B; Arns BM; Klepetko W; Zielinski CC; Zöchbauer-Müller S
    J Pathol; 2018 Aug; 245(4):387-398. PubMed ID: 29570800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
    Zhang Y; Miao Y; Yi J; Wang R; Chen L
    Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.
    Horie M; Kaczkowski B; Ohshima M; Matsuzaki H; Noguchi S; Mikami Y; Lizio M; Itoh M; Kawaji H; Lassmann T; Carninci P; Hayashizaki Y; Forrest ARR; Takai D; Yamaguchi Y; Micke P; Saito A; Nagase T
    Mol Cancer Res; 2017 Oct; 15(10):1354-1365. PubMed ID: 28698358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of enhancer methylation for epigenetic regulation of tumorigenesis in squamous lung cancer.
    Cho JW; Shim HS; Lee CY; Park SY; Hong MH; Lee I; Kim HR
    Exp Mol Med; 2022 Jan; 54(1):12-22. PubMed ID: 34987166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of HERC5 and its potential role in NSCLC progression.
    Wrage M; Hagmann W; Kemming D; Uzunoglu FG; Riethdorf S; Effenberger K; Westphal M; Lamszus K; Kim SZ; Becker N; Izbicki JR; Sandoval J; Esteller M; Pantel K; Risch A; Wikman H
    Int J Cancer; 2015 May; 136(10):2264-72. PubMed ID: 25353388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway.
    Sun CC; Zhu W; Li SJ; Hu W; Zhang J; Zhuo Y; Zhang H; Wang J; Zhang Y; Huang SX; He QQ; Li DJ
    Genome Med; 2020 Sep; 12(1):77. PubMed ID: 32878637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers.
    Imoto I; Izumi H; Yokoi S; Hosoda H; Shibata T; Hosoda F; Ohki M; Hirohashi S; Inazawa J
    Cancer Res; 2006 May; 66(9):4617-26. PubMed ID: 16651412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical and bioinformatic analysis of hemimethylation patterns in non-small cell lung cancer.
    Sun S; Zane A; Fulton C; Philipoom J
    BMC Cancer; 2021 Mar; 21(1):268. PubMed ID: 33711952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters.
    Yoo S; Bieda MC
    BMC Genomics; 2014 Aug; 15(1):724. PubMed ID: 25163646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.